210 related articles for article (PubMed ID: 33772854)
1. The KDIGO guidelines on diabetes and chronic kidney disease, 2020: An appraisal.
Kalra S
Diabet Med; 2021 Jul; 38(7):e14561. PubMed ID: 33772854
[No Abstract] [Full Text] [Related]
2. [French translation of the clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher (eGFR<45mL/min/1.73 m
Jourde-Chiche N; Guerrot D; Chauveau D; Boffa JJ
Nephrol Ther; 2017 May; 13(3):138-145. PubMed ID: 28010941
[No Abstract] [Full Text] [Related]
3. Updated management of chronic kidney disease in patients with diabetes.
Hass VM
JAAPA; 2014 Jun; 27(6):17-22. PubMed ID: 24819952
[TBL] [Abstract][Full Text] [Related]
4. Is a target hemoglobin A1c below 7% safe in dialysis patients?
Halevy D; Vemireddy M
Am J Kidney Dis; 2007 Jul; 50(1):166; author reply 166-7. PubMed ID: 17591538
[No Abstract] [Full Text] [Related]
5. [HbA1c 8.5% in elderly people with diabetes: is it good enough?].
Bottermann P
MMW Fortschr Med; 2009 Jun; 151(26-29):38-9. PubMed ID: 19739547
[No Abstract] [Full Text] [Related]
6. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
Patel PA; Liang L; Khazanie P; Hammill BG; Fonarow GC; Yancy CW; Bhatt DL; Curtis LH; Hernandez AF
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413035
[TBL] [Abstract][Full Text] [Related]
7. Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations - a registry-based analysis.
Bramlage P; Lanzinger S; Tittel SR; Hess E; Fahrner S; Heyer CHJ; Friebe M; Buschmann I; Danne T; Seufert J; Holl RW
BMC Nephrol; 2021 May; 22(1):184. PubMed ID: 34011313
[TBL] [Abstract][Full Text] [Related]
8. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
[TBL] [Abstract][Full Text] [Related]
9. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
Kidney Int; 2022 Nov; 102(5S):S1-S127. PubMed ID: 36272764
[No Abstract] [Full Text] [Related]
10. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
Kidney Int; 2020 Oct; 98(4S):S1-S115. PubMed ID: 32998798
[No Abstract] [Full Text] [Related]
11. Medical Management of the Diabetic Patient.
Clement S
Clin Podiatr Med Surg; 2019 Jul; 36(3):349-354. PubMed ID: 31079601
[TBL] [Abstract][Full Text] [Related]
12. Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study.
Ruilope L; Hanefeld M; Lincoff AM; Viberti G; Meyer-Reigner S; Mudie N; Wieczorek Kirk D; Malmberg K; Herz M
BMC Nephrol; 2014 Nov; 15():180. PubMed ID: 25407798
[TBL] [Abstract][Full Text] [Related]
13. HbA1c and beyond.
Rossing P
Nephrol Dial Transplant; 2023 Jan; 38(1):34-40. PubMed ID: 34383945
[TBL] [Abstract][Full Text] [Related]
14. The glycation gap and estimated glomerular filtration rate in individuals without diabetes mellitus.
Shipman KE; Jawad M; Sullivan KM; Ford C; Gama R
Clin Chem; 2014 Oct; 60(10):1346-7. PubMed ID: 25070858
[No Abstract] [Full Text] [Related]
15. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution.
Lamb EJ; Levey AS; Stevens PE
Clin Chem; 2013 Mar; 59(3):462-5. PubMed ID: 23449698
[No Abstract] [Full Text] [Related]
16. DPP-4 Inhibitors in Diabetic Patients with Chronic Kidney Disease and End-Stage Kidney Disease on Dialysis in Clinical Practice.
Abe M; Okada K
Contrib Nephrol; 2015; 185():98-115. PubMed ID: 26023019
[TBL] [Abstract][Full Text] [Related]
17. The application of evidence-based principles of care in older persons (issue 3): management of diabetes mellitus.
Zarowitz BJ; Tangalos EG; Hollenack K; O'Shea T
J Am Med Dir Assoc; 2006 May; 7(4):234-40. PubMed ID: 16698510
[No Abstract] [Full Text] [Related]
18. Diabetes pharmacotherapy in 2012: considerations in medication selection.
Cornell S; Dorsey VJ
Postgrad Med; 2012 Jul; 124(4):84-94. PubMed ID: 22913897
[TBL] [Abstract][Full Text] [Related]
19. [Perspectives in diabetes 2011: dialogue - experience - benefit].
Kordonouri O
Dtsch Med Wochenschr; 2011 May; 136(21):1105. PubMed ID: 21590627
[No Abstract] [Full Text] [Related]
20. Liraglutide preserves renal function in overweight diabetic patients with stage 3 chronic kidney disease.
de Lucas MDG; Bueno BA; Sierra JO
Eur J Intern Med; 2017 Oct; 44():e28-e29. PubMed ID: 28711390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
